Apertura Logo
  • Our Platforms
  • About Us
  • News
    • Press Releases
    • f-stop
  • Careers
  • Contact Us

News & Resources


Warning: is_a() expects parameter 2 to be string, object given in /home/customer/www/aperturagtx.com/public_html/wp-content/themes/apertura/template-parts/content.php on line 19

Apertura Appoints Gene Therapy Executive Joseph La Barge as Chief Executive Officer

Uncategorized
Apertura Gene Therapy announced the appointment of gene therapy executive Joseph La Barge as Chief Executive Officer.
Read More

Apertura Announces Fit4Function AAV Capsid Engineering Platform and In Vivo Proof-of-Concept Data to Be Presented at the 25ᵗʰ Annual Meeting of the American Society of Gene and Cell Therapy (ASGCT)

Uncategorized
NEW YORK and CAMBRIDGE, Mass., May 4, 2022 – Apertura Gene Therapy, a biotechnology company opening opportunities for treating debilitating diseases with limited options for patients, today announced that its academic collaborators will present findings on the Fit4Function AAV capsid engineering platform and non-human primate proof-of-concept data at the 25th Annual Meeting of the American Society of […]
Read More

Apertura Gene Therapy Launches with $67M Series A Financing from Deerfield and an Innovative Technology Platform to Develop Genetic Medicines

Uncategorized
Founded on platform technologies developed by Broad Institute of MIT and Harvard and Harvard Medical School Investigators
Read More
Apertura Footer Logo
  • Contact us
  • Join us
  • Social Media Item
  • Social Media Item
©2023 Apertura Gene Therapy. All Rights Reserved.
  • Terms of Use
  • Privacy Policy